• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后 50-64 岁女性骨质疏松临床风险评估工具的比较评估

Comparative Evaluation of Osteoporosis Clinical Risk Assessment Tools in Postmenopausal Women Aged 50-64.

机构信息

Vioapeikonisi OE Imaging Lab, Heraklion Crete, Greece.

Radiology Department, General Hospital of Athens "G. Gennimatas", Athens, Greece.

出版信息

J Musculoskelet Neuronal Interact. 2024 Dec 1;24(4):377-384.

PMID:39616507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11609562/
Abstract

OBJECTIVES

To assess the performance of five osteoporosis clinical risk assessment tools (SCORE, ORAI, ABONE, OST and OSIRIS), in a subgroup of young postmenopausal women aged 50-64, who underwent DXA screening.

METHODS

The above-mentioned osteoporosis risk assessment tools were calculated for 258 young postmenopausal women (aged 50-64) who had a DXA scan, in Crete/Greece.

RESULTS

Patients with a T-score ≤ -2.5 or a T-score ≤ -2.0 had a statistically significant higher value of SCORE, ORAI and ABONE and a lower value of OST, OSIRIS, and OSIRIS Adjusted Score, compared to the patients with T-score > -2.5 and T-score > -2.0, respectively. ORAI (T-score≤ -2.0) and OST (T-score≤ -2.5) demonstrated the highest sum of sensitivity and specificity. CHAID analysis further confirmed the relative significance of the OST tool in the osteoporosis group (T-score≤ -2.5 vs. T-score > -2.5), for a cut-off of 2.8. In the other group (T-score ≤ -2.0 vs T-score > -2.0) the ORAI score showed a significantly important relationship for a cut-off of 8.

CONCLUSION

OST, despite its performance limitations, correlates best with the DXA measurements of young (50-64), postmenopausal osteoporotic women, a fact which may suggest its' potential role as a screening tool in this specific age group.

摘要

目的

评估 5 种骨质疏松临床风险评估工具(SCORE、ORAI、ABONE、OST 和 OSIRIS)在接受 DXA 筛查的 50-64 岁年轻绝经后女性亚组中的性能。

方法

为在克里特岛/希腊接受 DXA 扫描的 258 名年轻绝经后(50-64 岁)女性计算了上述骨质疏松风险评估工具。

结果

与 T 评分> -2.5 和 T 评分> -2.0 的患者相比,T 评分≤-2.5 或 T 评分≤-2.0 的患者的 SCORE、ORAI 和 ABONE 值具有统计学意义更高,而 OST、OSIRIS 和 OSIRIS 调整评分则更低。ORAI(T 评分≤-2.0)和 OST(T 评分≤-2.5)表现出最高的敏感性和特异性总和。CHAID 分析进一步证实了 OST 工具在骨质疏松组(T 评分≤-2.5 与 T 评分>-2.5)中的相对重要性,截断值为 2.8。在另一组(T 评分≤-2.0 与 T 评分>-2.0)中,ORAI 评分与 T 评分>-2.0 相比具有显著的重要关系,截断值为 8。

结论

OST 尽管性能有限,但与年轻(50-64 岁)绝经后骨质疏松女性的 DXA 测量结果相关性最佳,这一事实可能表明其在特定年龄组中作为筛查工具的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/a520cae842c1/JMNI-24-377-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/9560e5271f33/JMNI-24-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/f5deeef0b4fa/JMNI-24-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/17c7d196a5f5/JMNI-24-377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/a520cae842c1/JMNI-24-377-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/9560e5271f33/JMNI-24-377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/f5deeef0b4fa/JMNI-24-377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/17c7d196a5f5/JMNI-24-377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11609562/a520cae842c1/JMNI-24-377-g004.jpg

相似文献

1
Comparative Evaluation of Osteoporosis Clinical Risk Assessment Tools in Postmenopausal Women Aged 50-64.绝经后 50-64 岁女性骨质疏松临床风险评估工具的比较评估
J Musculoskelet Neuronal Interact. 2024 Dec 1;24(4):377-384.
2
Comparative accuracy of osteoporosis risk assessment tools in postmenopausal women: A systematic review and network meta-analysis.绝经后女性骨质疏松症风险评估工具的比较准确性:一项系统评价和网状荟萃分析。
Int J Nurs Stud. 2025 May;165:105029. doi: 10.1016/j.ijnurstu.2025.105029. Epub 2025 Feb 17.
3
Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools.使用美国预防服务工作组(USPSTF)推荐的骨质疏松症风险评估工具识别绝经后骨质疏松症的年轻女性。
JAMA Netw Open. 2025 Mar 3;8(3):e250626. doi: 10.1001/jamanetworkopen.2025.0626.
4
Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit.选择女性进行骨密度检测的决策规则:在转诊至骨密度测量单位的绝经后女性中的应用。
J Rheumatol. 2007 Jun;34(6):1307-12.
5
Comparisons of Different Screening Tools for Identifying Fracture/Osteoporosis Risk Among Community-Dwelling Older People.不同筛查工具用于识别社区居住老年人骨折/骨质疏松症风险的比较
Medicine (Baltimore). 2016 May;95(20):e3415. doi: 10.1097/MD.0000000000003415.
6
Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.四种临床筛查工具用于选择围绝经期和绝经后早期妇女进行双能X线吸收测定的性能。
Osteoporos Int. 2005 Jul;16(7):764-72. doi: 10.1007/s00198-004-1748-5. Epub 2004 Sep 30.
7
Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.绝经后女性骨质疏松症筛查的风险评估工具:一项系统综述
Curr Osteoporos Rep. 2015 Oct;13(5):287-301. doi: 10.1007/s11914-015-0282-z.
8
Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium.骨质疏松自我评估工具(OST)在比利时白种人群中的验证与比较评估。
QJM. 2004 Jan;97(1):39-46. doi: 10.1093/qjmed/hch002.
9
Comparison of questionnaire and quantitative ultrasound techniques as screening tools for DXA.问卷调查与定量超声技术作为双能X线吸收法筛查工具的比较。
Osteoporos Int. 2005 Dec;16(12):1565-75. doi: 10.1007/s00198-005-1864-x. Epub 2005 May 10.
10
Evaluation of Different Screening Tools for Predicting Femoral Neck Osteoporosis in Rural South Indian Postmenopausal Women.评估不同筛查工具对印度南部农村绝经后妇女股骨颈骨质疏松症的预测作用
J Clin Densitom. 2018 Jan-Mar;21(1):119-124. doi: 10.1016/j.jocd.2017.08.002. Epub 2017 Sep 27.

引用本文的文献

1
A high FT3 level might protect bone mineral density among euthyroid type 2 diabetes mellitus patients.较高的游离三碘甲状腺原氨酸(FT3)水平可能对甲状腺功能正常的2型糖尿病患者的骨密度具有保护作用。
Endocr Connect. 2025 Jun 13;14(6). doi: 10.1530/EC-25-0110. Print 2025 Jun 1.

本文引用的文献

1
DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry.DXA 报告更新:2023 年国际临床密度测定学会官方立场。
J Clin Densitom. 2024 Jan-Mar;27(1):101437. doi: 10.1016/j.jocd.2023.101437. Epub 2023 Nov 2.
2
Ten existing osteoporosis prediction tools for the successful application of National Health Insurance-reimbursed anti-osteoporosis medications in long-term care residents in Taiwan.台湾长期照护居民成功应用医保报销抗骨质疏松药物的十种现有骨质疏松症预测工具。
J Formos Med Assoc. 2023 Feb;122(2):139-147. doi: 10.1016/j.jfma.2022.08.009. Epub 2022 Aug 28.
3
Dual-energy X-ray absorptiometry (DXA) to measure bone mineral density (BMD) for diagnosis of osteoporosis - experimental data from artificial vertebrae confirms significant dependence on bone size.
采用双能X线吸收法(DXA)测量骨密度(BMD)以诊断骨质疏松症——来自人工椎体的实验数据证实其对骨骼大小有显著依赖性。
Bone Rep. 2022 Jul 25;17:101607. doi: 10.1016/j.bonr.2022.101607. eCollection 2022 Dec.
4
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(Suppl 1):1-46. doi: 10.4158/GL-2020-0524SUPPL.
5
The 2018 Guidelines for the diagnosis and treatment of osteoporosis in Greece.《2018 年希腊骨质疏松症诊断与治疗指南》。
Arch Osteoporos. 2019 Mar 15;14(1):39. doi: 10.1007/s11657-019-0584-3.
6
Association between age at menopause and fracture risk: a systematic review and meta-analysis.绝经年龄与骨折风险的关联:系统评价和荟萃分析。
Endocrine. 2019 Feb;63(2):213-224. doi: 10.1007/s12020-018-1746-6. Epub 2018 Sep 10.
7
Performance of Osteoporosis Self-Assessment Tool (OST) in Predicting Osteoporosis-A Review.骨质疏松症自我评估工具(OST)在预测骨质疏松症中的性能评价综述。
Int J Environ Res Public Health. 2018 Jul 9;15(7):1445. doi: 10.3390/ijerph15071445.
8
Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.骨质疏松症筛查以预防骨折:美国预防服务工作组推荐声明。
JAMA. 2018 Jun 26;319(24):2521-2531. doi: 10.1001/jama.2018.7498.
9
Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.骨质疏松性骨折的筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Jun 26;319(24):2532-2551. doi: 10.1001/jama.2018.6537.
10
Osteoporosis: A Review of Treatment Options.骨质疏松症:治疗方案综述
P T. 2018 Feb;43(2):92-104.